Main Markets of Activity
- Alzheimers
- Anxiety
- Dementia
- Depressive Disorders
- Epilepsy
- Multiple Sclerosis
- Obesity
- Parkinson’s Disease
- Sleep Disorders
- Vision Disorders Neurowellness
- Digital health
The direct cost of brain disorders on global health care systems is tremendous – in the US alone it is estimated to be around $700b. Medicines were intended to be the first line of combat, but they are failing. At the same time Health care systems are becoming unsustainable, resulting in a direct need to bring medical devices into the community.
Thus the goal today in Neuroscience is to discover new solutions for as yet unmet problems, but at the same time also optimize costs by finding cheaper solutions, and the main emphasis must be on earlier diagnosis which leads to earlier treatment that can avoid hospitalizations. This is why Neuro Science innovators are now taking center stage while SENSOMEDICAL brings their research and ideas to fruition in the form of practical, comfortable, “analyzable” wearable Neuro Products and active implants that treat, diagnose, process, analyze and store the accumulated data – to aid in the determination of the desired medical solution – including the all-important treatment, diagnosis, drug optimization and discovery – to alleviate the ailment or further aid research based scientific processes.